- UPSpace Home
- →
- Health Sciences
- →
- Nuclear Medicine
- →
- Browsing Nuclear Medicine by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Nuclear Medicine by Subject "Radiopharmaceuticals"
Now showing items 1-6 of 6
-
(Bentham Science, 2018)Diabetic Foot Infections (DFIs) are associated with increased morbidity, an economic burden on patients, their families and healthcare systems and increased mortality. Early diagnosis with prompt, appropriate and adequate ...
-
Novel receptor tyrosine kinase pathway inhibitors for targeted radionuclide therapy of glioblastoma (MDPI, 2021-06)Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is common in GB, which subsequently ...
-
(Allergy Society of South Africa, 2015-03)Immunologic reactions to radiopharmaceuticals are usually mild and transient and require little or no medical treatment. As the usage of radiopharmaceuticals has increased, the reported adverse reactions remain ...
-
(Elsevier, 2023-09)It is important to constantly monitor developments in the preclinical imaging arena of infection. Firstly, novel radiopharmaceuticals with the correct characteristics must be identified to funnel into the clinic. Secondly, ...
-
(Elsevier, 2018-10)INTRODUCTION : Drug delivery systems are entities designed to alter the biological behaviour of the pharmaceutical active ingredients that they carry in order to afford more beneficial biodistribution and safety profiles. ...
-
(Hindawi Publishing, 2015)Noninvasive imaging is a powerful tool for early diagnosis and monitoring of various disease processes, such as infections. An alarming shortage of infection-selective radiopharmaceuticals exists for overcoming the diagnostic ...
Now showing items 1-6 of 6